VR Education's ENGAGE platform selected for medical training app
Francesca Morgan
Company News - 2 mins
10:07, 14th November 2019

Virtual reality firm focused on the education sector, VR Education (VRE) FOLLOW, announced on Thursday the roll-out of its ENGAGE platform with medical training app, Life-saving Instruction for Emergencies.

Developed with Oxford University, HTC, and the KEMRI-Welcome Trust Research Programme, LIFE will launch the platform today with VR Education at the Council of International Neonatal Nurses conference in Nairobi, Kenya.

The app benefits healthcare workers by allowing them to deal with virtual patients via their smartphone or headset -- the group believes the app could “dramatically improve outcomes” in low-resource areas where access to simulation training is limited or expensive.

"Operating via our versatile ENGAGE platform, LIFE has been designed to provide healthcare workers with universal access to high quality medical education and offers the potential to dramatically promote access to life-saving knowledge in developing nations,” said David Whelan, CEO of VR Education.

The LIFE smartphone app is now being rolled out across Kenya through partnerships with medical and nursing schools and professional organisations such as the Kenya Paediatric Association.

“Supporting LIFE on a pro bono basis will increase awareness of our ENGAGE platform with medical professionals and students which we are confident will lead to enquiries from medical trainers seeking to host their own applications on the ENGAGE platform on a paid basis," Mr Whelan further commented.

“By using immersive VR simulation training in combination with a personal smartphone app, the LIFE project has the potential to support healthcare worker training at scale,” added Dr Chris Paton, the lead researcher for LIFE from the University of Oxford.

Follow News & Updates from VR Education here: FOLLOW

Disclaimer & Declaration of Interest

The information, investment views and recommendations in this article are provided for general information purposes only. Nothing in this article should be construed as a solicitation to buy or sell any financial product relating to any companies under discussion or to engage in or refrain from doing so or engaging in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the writer but no responsibility is accepted for actions based on such opinions or comments. Vox Markets may receive payment from companies mentioned for enhanced profiling or publication presence. The writer may or may not hold investments in the companies under discussion.

Comments
info
Login or register to post comments

Recent Articles
Watchlist